PAX5 and precursor B-cell acute lymphoblastic leukemia: In B-ALL, PAX5 genetic alterations are a hallmark and characterize 31% of cases, involving deletions, translocation, and point mutations, and result in dedifferentiation of pro-B cells and aggressive lymphomagenesis [45,46].